Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice

MLA

Makiko Nakayama, et al. “Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice.” Journal of the American Society of Nephrology, vol. 30, Feb. 2019, pp. 393–405. EBSCOhost, https://doi.org/10.1681/asn.2018060625.

APA

Makiko Nakayama, Johannes Wedel, Eugen Widmeier, Merlin Airik, Anish Nag, Catherine F. Clarke, Hannah Hugo, Rannar Airik, Jang Cho, Ronen Schneider, Markus Schueler, David Schapiro, Friedhelm Hildebrandt, Chandra C. Ghosh, & Agape M. Awad. (2019). Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice. Journal of the American Society of Nephrology, 30, 393–405. https://doi.org/10.1681/asn.2018060625

Chicago

Makiko Nakayama, Johannes Wedel, Eugen Widmeier, Merlin Airik, Anish Nag, Catherine F. Clarke, Hannah Hugo, et al. 2019. “Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice.” Journal of the American Society of Nephrology 30 (February): 393–405. doi:10.1681/asn.2018060625.